1. [Comparison among endoscopic variceal obliteration, endoscopic band ligation, and balloon-occluded retrograde transvenous obliteration for treatment of gastric variceal bleeding].
- Author
-
Min SK, Kim SG, Kim YS, Bae JY, Lee JC, Lee SH, Kim HS, Jeong SW, Jang JY, Moon JH, Lee MS, and Kim BS
- Subjects
- Adult, Aged, Enbucrilate therapeutic use, Endoscopy, Gastrointestinal, Esophageal and Gastric Varices complications, Female, Gastrointestinal Hemorrhage complications, Gastrointestinal Hemorrhage mortality, Humans, Ligation, Liver Cirrhosis complications, Male, Middle Aged, Recurrence, Retrospective Studies, Severity of Illness Index, Balloon Occlusion, Esophageal and Gastric Varices therapy, Gastrointestinal Hemorrhage therapy
- Abstract
Background/aims: Endoscopic variceal obliteration (EVO), endoscopic variceal ligation (EVL), and balloon-occluded retrograde transvenous obliteration (BRTO) are used to manage gastric variceal bleeding. We compared the re-bleeding rates and survival times of these modalities., Methods: The study enrolled 103 patients with suspected gastric variceal bleeding between July 2001 and May 2009. For the management of gastric variceal bleeding, 52 patients underwent EVO; 36, EVL; and 15, BRTO. We evaluated their laboratory results and vital signs, and calculated the Child score, Child classification, and Model for End-stage Liver Disease score. Rebleeding was defined as new-onset hematemesis, hematochezia, melena, or endoscopically proven bleeding. Time-to-rebleeding and survival time were examined by Kaplan-Meyer analysis. A value of p<0.05 indicated statistical significance., Results: There were no significant differences in baseline characteristics among the three groups. The overall follow-up period averaged 65.13 months. During follow-up, rebleeding occurred in 17 patients (11 EVO, 5 EVL, and 1 BRTO). The times-to-rebleeding were 63.59, 75.79, and 51.41 months for EVO, EVL, and BRTO, respectively, and did not differ significantly (p=0.515). The median survival times were 77.42, 70.14, and 42.79 months, respectively, and also were not different significantly (p=0.978)., Conclusions: There were no significant differences in the time-to-rebleeding or survival time among EVO, EVL, and BRTO. Further prospective, large-scale studies are needed.
- Published
- 2011
- Full Text
- View/download PDF